首页 > 最新文献

Russian Journal for Personalized Medicine最新文献

英文 中文
Patients with Fontan circulation: long-term complications and follow-up strategy 方坦循环患者:长期并发症和随访策略
Pub Date : 2024-06-11 DOI: 10.18705/2782-3806-2024-4-2-114-128
E. V. Kharakterova, A. A. Ivanilova, S. Fetisova, A. Y. Kulpina, O. Kofeynikova, T. Vershinina, T. Pervunina, E. Vasichkina
The Fontan operation is a palliative surgical correction, which is performed on children with congenital heart defects (CHD) in cases when surgical creation of two equally working ventricles is impossible. Today there are about 70,000 patients with Fontan circulation all over the world. Due to improvement of methods in early detection and treatment of CHD, as well as monitoring algorithms, an increasing number of patients with a single ventricle (SV) stay alive until adulthood.However, this group’s mortality is still quite high, despite the constant development of the surgery approach using modern technical equipment and high-tech examination methods. Chronic increase in systemic venous pressure, non-physiological passive pulmonary blood flow and progressive heart failure (HF) with a decreasing cardiac output (CO) gradually lead to complications from other organs and systems. That is why a multidisciplinary approach and development of optimal management tactics are required to follow-up patients with Fontan hemodynamics.Thus, the purpose of our work was to analyze and summarize current data of the management strategy and timely diagnosis complications in patients with Fontan circulation.
丰坦手术是一种姑息性外科矫正手术,适用于无法通过手术建立两个同样工作的心室的先天性心脏缺陷(CHD)患儿。目前,全世界约有 7 万名丰坦循环患者。由于早期发现和治疗先天性心脏病的方法以及监测算法的改进,越来越多的单心室(SV)患者能活到成年。然而,尽管使用现代技术设备和高科技检查方法的手术方法不断发展,但这一群体的死亡率仍然很高。全身静脉压的长期升高、非生理性的被动肺血流以及心输出量(CO)下降的进行性心力衰竭(HF)会逐渐导致其他器官和系统的并发症。因此,我们的工作旨在分析和总结丰坦循环患者的管理策略和及时诊断并发症的现有数据。
{"title":"Patients with Fontan circulation: long-term complications and follow-up strategy","authors":"E. V. Kharakterova, A. A. Ivanilova, S. Fetisova, A. Y. Kulpina, O. Kofeynikova, T. Vershinina, T. Pervunina, E. Vasichkina","doi":"10.18705/2782-3806-2024-4-2-114-128","DOIUrl":"https://doi.org/10.18705/2782-3806-2024-4-2-114-128","url":null,"abstract":"The Fontan operation is a palliative surgical correction, which is performed on children with congenital heart defects (CHD) in cases when surgical creation of two equally working ventricles is impossible. Today there are about 70,000 patients with Fontan circulation all over the world. Due to improvement of methods in early detection and treatment of CHD, as well as monitoring algorithms, an increasing number of patients with a single ventricle (SV) stay alive until adulthood.However, this group’s mortality is still quite high, despite the constant development of the surgery approach using modern technical equipment and high-tech examination methods. Chronic increase in systemic venous pressure, non-physiological passive pulmonary blood flow and progressive heart failure (HF) with a decreasing cardiac output (CO) gradually lead to complications from other organs and systems. That is why a multidisciplinary approach and development of optimal management tactics are required to follow-up patients with Fontan hemodynamics.Thus, the purpose of our work was to analyze and summarize current data of the management strategy and timely diagnosis complications in patients with Fontan circulation.","PeriodicalId":499018,"journal":{"name":"Russian Journal for Personalized Medicine","volume":"45 16","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141355156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare variant of the development of the proarrhythmogenic effect of etacizine in a child with chronic kidney disease (clinical case) 慢性肾病患儿依他西嗪促心律失常作用的罕见变异发展(临床病例)
Pub Date : 2024-06-11 DOI: 10.18705/2782-3806-2024-4-2-180-188
O. V. Kotomina, V. V. Pogodin, Yu. L. Pazgaleva
This article describes a rare clinical case of the development of severe ventricular tachycardia while taking etacizine in a 3-year-8-month-old patient with chronic kidney disease. A clinical case demonstrates the pharmacodynamics and pharmacokinetics of class 1C antiarrhythmic drugs in pediatric patients with kidney pathology.
本文描述了一例罕见的临床病例,一名 3 岁 8 个月大的慢性肾病患者在服用依他西嗪期间出现了严重的室性心动过速。该临床病例展示了 1C 类抗心律失常药物在患有肾病的儿科患者中的药效学和药代动力学。
{"title":"A rare variant of the development of the proarrhythmogenic effect of etacizine in a child with chronic kidney disease (clinical case)","authors":"O. V. Kotomina, V. V. Pogodin, Yu. L. Pazgaleva","doi":"10.18705/2782-3806-2024-4-2-180-188","DOIUrl":"https://doi.org/10.18705/2782-3806-2024-4-2-180-188","url":null,"abstract":"This article describes a rare clinical case of the development of severe ventricular tachycardia while taking etacizine in a 3-year-8-month-old patient with chronic kidney disease. A clinical case demonstrates the pharmacodynamics and pharmacokinetics of class 1C antiarrhythmic drugs in pediatric patients with kidney pathology.","PeriodicalId":499018,"journal":{"name":"Russian Journal for Personalized Medicine","volume":"31 25","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141355476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design of metabolomic studies: pre-analytical process 代谢组学研究的设计:分析前过程
Pub Date : 2024-06-11 DOI: 10.18705/2782-3806-2024-4-2-145-155
E. D. Kessenikh, E. A. Osintseva, M. А. Migunova, M. I. Krivosheina, E. A. Murashko
Metabolomics is the comprehensive analysis of small molecules involved in metabolic pathways that control biochemical processes and functions of cells in the body. Metabolomic studies consist of three major steps: pre-analytical, analytical and post-analytical. The review emphasizes the importance of the pre-analytical stage, which is the journey of a biosample from the patient to the biobank and then to the analytical laboratory. Based on the literature analysis, the review presents the factors that influence the quality of the sample and therefore the quality of the final research result: clinical information collection, biosample selection, biosample collection and processing, and subsequent storage. Proper design of metabolomic studies, quality control of samples from collection to analysis by physicochemical methods provides data that can improve the quality of disease diagnosis, provide a transition to personalized medicine.
代谢组学是对参与控制体内细胞生化过程和功能的代谢途径的小分子进行的综合分析。代谢组学研究包括三个主要步骤:分析前、分析和分析后。综述强调了分析前阶段的重要性,即生物样本从患者到生物库再到分析实验室的过程。根据文献分析,综述介绍了影响样本质量并进而影响最终研究结果质量的因素:临床信息收集、生物样本选择、生物样本收集和处理以及后续储存。代谢组学研究的合理设计、样本从采集到理化方法分析的质量控制所提供的数据可以提高疾病诊断的质量,为个性化医疗提供过渡。
{"title":"Design of metabolomic studies: pre-analytical process","authors":"E. D. Kessenikh, E. A. Osintseva, M. А. Migunova, M. I. Krivosheina, E. A. Murashko","doi":"10.18705/2782-3806-2024-4-2-145-155","DOIUrl":"https://doi.org/10.18705/2782-3806-2024-4-2-145-155","url":null,"abstract":"Metabolomics is the comprehensive analysis of small molecules involved in metabolic pathways that control biochemical processes and functions of cells in the body. Metabolomic studies consist of three major steps: pre-analytical, analytical and post-analytical. The review emphasizes the importance of the pre-analytical stage, which is the journey of a biosample from the patient to the biobank and then to the analytical laboratory. Based on the literature analysis, the review presents the factors that influence the quality of the sample and therefore the quality of the final research result: clinical information collection, biosample selection, biosample collection and processing, and subsequent storage. Proper design of metabolomic studies, quality control of samples from collection to analysis by physicochemical methods provides data that can improve the quality of disease diagnosis, provide a transition to personalized medicine.","PeriodicalId":499018,"journal":{"name":"Russian Journal for Personalized Medicine","volume":"31 18","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141357219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of collagen dressings in the complex treatment of diabetic foot ulcers 胶原蛋白敷料在糖尿病足溃疡综合治疗中的作用
Pub Date : 2024-06-11 DOI: 10.18705/2782-3806-2024-4-2-139-145
Yuliya Lutsenko, Yu. G. Abramova, A. B. Matiytsiv
The prevalence of diabetes mellitus (DM) in the population aged 20–79 years has reached more than half a billion people, representing about 10.5 % of the adult population on the planet. The risk of developing diabetic foot ulcers ranges from 19 to 34 % with a recurrence rate of 65 % within 5 years.The aim of the study: to evaluate the efficacy of dressings containing lyophilized collagen solution in the complex treatment of chronic diabetic foot ulcers.Materials and methods. 101 patients with diabetic foot ulcers (degree of foot lesions I–II according to Wagner) were under observation: in I (main) group — 52 patients — we used dressings containing lyophilized collagen solution (Zelenaya Dubrava, ZAO, RF), in II (comparison group) — 49 patients — traditional local treatment. Planimetric indices of the wound surface were measured using the MultiSpec program, and the assessment of treatment efficacy was determined as the ratio of the final area and depth of the wound to the initial values in percent. Results and their discussion. On admission, the wound area in the main group was 4.3 ± 3.7 cm2, whereas in the comparison group it was 4.1 ± 3.6 cm2. The final wound area (by 4-week measurement) decreased to 1.2 ± 1.3 cm2 in group I, whereas it was 2.6 ± 3.5 cm2 in group II. On 8–10 days after removal of purulent-necrotic tissues in the first group clinically there was a significant reduction of finger edema, cytologically there was no microflora in the wound discharge, phagocytosis was completed, whereas in the second group there was an inflammatory reaction (single areas of lysed leukocytes alternated with accumulation of leukocytes up to ¼ in f/v).Conclusions. Cytologically the effectiveness of collagen dressings application in complex treatment of diabetic foot ulcers was proved: by the end of the second week absence of inflammatory reaction and presence of proliferation signs in the majority of 69,4 % of patients. Planimetrically positive dynamics of the wound process was established: reduction of the area by the end of the 4th week in comparison with the initial one by 45,1 ± 33,8 % at traditional methods of treatment and by 79,9 ± 16,4 % at local use of collagen dressings, and depth — 53,1 ± 37,5 % and 76,8 ± 18,6 % respectively.
糖尿病(DM)在 20-79 岁人群中的发病率已超过 5 亿,约占全球成年人口的 10.5%。患糖尿病足溃疡的风险为 19% 至 34%,5 年内复发率为 65%。研究目的:评估含有冻干胶原蛋白溶液的敷料在慢性糖尿病足溃疡复合治疗中的疗效。101名糖尿病足溃疡患者(根据瓦格纳标准,足部病变程度为I-II级)接受了观察:I组(主要组)52名患者使用了含冻干胶原蛋白溶液的敷料(泽勒纳亚-杜布拉瓦,ZAO,RF),II组(对比组)49名患者使用了传统的局部治疗方法。我们使用 MultiSpec 程序测量了伤口表面的平面指数,并以最终面积和伤口深度与初始值之比(百分比)来评估疗效。结果及讨论入院时,主要治疗组的伤口面积为 4.3 ± 3.7 平方厘米,对比组为 4.1 ± 3.6 平方厘米。第一组的最终伤口面积(4 周后测量)减小到 1.2 ± 1.3 平方厘米,而第二组为 2.6 ± 3.5 平方厘米。清除化脓坏死组织后 8-10 天,第一组的手指水肿明显减轻,从细胞学角度看,伤口分泌物中没有微生物菌群,吞噬作用已经完成,而第二组则出现了炎症反应(单个区域的白细胞溶解与白细胞堆积交替出现,白细胞的体积比高达 1/4)。从细胞学角度证明了胶原蛋白敷料在糖尿病足溃疡综合治疗中的有效性:在第二周结束时,大多数 69.4% 的患者没有出现炎症反应,而出现了增殖迹象。从平面测量的角度来看,伤口进程呈现出积极的动态变化:在第四周结束时,与最初相比,传统治疗方法的面积减少了 45.1 ± 33.8 %,而局部使用胶原蛋白敷料的面积减少了 79.9 ± 16.4 %,深度分别减少了 53.1 ± 37.5 % 和 76.8 ± 18.6 %。
{"title":"The role of collagen dressings in the complex treatment of diabetic foot ulcers","authors":"Yuliya Lutsenko, Yu. G. Abramova, A. B. Matiytsiv","doi":"10.18705/2782-3806-2024-4-2-139-145","DOIUrl":"https://doi.org/10.18705/2782-3806-2024-4-2-139-145","url":null,"abstract":"The prevalence of diabetes mellitus (DM) in the population aged 20–79 years has reached more than half a billion people, representing about 10.5 % of the adult population on the planet. The risk of developing diabetic foot ulcers ranges from 19 to 34 % with a recurrence rate of 65 % within 5 years.The aim of the study: to evaluate the efficacy of dressings containing lyophilized collagen solution in the complex treatment of chronic diabetic foot ulcers.Materials and methods. 101 patients with diabetic foot ulcers (degree of foot lesions I–II according to Wagner) were under observation: in I (main) group — 52 patients — we used dressings containing lyophilized collagen solution (Zelenaya Dubrava, ZAO, RF), in II (comparison group) — 49 patients — traditional local treatment. Planimetric indices of the wound surface were measured using the MultiSpec program, and the assessment of treatment efficacy was determined as the ratio of the final area and depth of the wound to the initial values in percent. Results and their discussion. On admission, the wound area in the main group was 4.3 ± 3.7 cm2, whereas in the comparison group it was 4.1 ± 3.6 cm2. The final wound area (by 4-week measurement) decreased to 1.2 ± 1.3 cm2 in group I, whereas it was 2.6 ± 3.5 cm2 in group II. On 8–10 days after removal of purulent-necrotic tissues in the first group clinically there was a significant reduction of finger edema, cytologically there was no microflora in the wound discharge, phagocytosis was completed, whereas in the second group there was an inflammatory reaction (single areas of lysed leukocytes alternated with accumulation of leukocytes up to ¼ in f/v).Conclusions. Cytologically the effectiveness of collagen dressings application in complex treatment of diabetic foot ulcers was proved: by the end of the second week absence of inflammatory reaction and presence of proliferation signs in the majority of 69,4 % of patients. Planimetrically positive dynamics of the wound process was established: reduction of the area by the end of the 4th week in comparison with the initial one by 45,1 ± 33,8 % at traditional methods of treatment and by 79,9 ± 16,4 % at local use of collagen dressings, and depth — 53,1 ± 37,5 % and 76,8 ± 18,6 % respectively.","PeriodicalId":499018,"journal":{"name":"Russian Journal for Personalized Medicine","volume":"22 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141357471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular mechanisms of thrombotic complications in glial tumors 胶质瘤血栓并发症的分子机制
Pub Date : 2024-06-11 DOI: 10.18705/2782-3806-2024-4-2-87-95
A. V. Savelyeva, Y. Zhilenkova, M. A. Simakova, O. V. Sirotkina
Cancer patients are at increased risk of venous thromboembolic complications (VTE), which are the second leading cause of death in these patients. Moreover, the maximum incidence of VTE occurs in tumors of the central nervous system [1]. Research is being conducted to identify laboratory biomarkers of increased risk of VTE, but to date data on their role are ambiguous. Patients with a mutation in the isocitrate dehydrogenase (IDH) gene are at lower risk of VTE, and the IDH mutation is associated with suppression of the production of tissue factor (TF) and podoplanin, the most studied molecules responsible for the occurrence of thromboembolic complications [2]. The main specific markers of VTE are based on immunohistochemical methods, which are possible only with histological examination of the tumor material. Therefore, it is important to find noninvasive biomarkers that could be used to assess the risk of venous thromboembolic complications. In this review, we will focus on highlighting the accumulated knowledge on this theme.
癌症患者罹患静脉血栓栓塞并发症(VTE)的风险增加,这是导致这些患者死亡的第二大原因。此外,中枢神经系统肿瘤的 VTE 发生率最高[1]。目前正在进行研究,以确定增加 VTE 风险的实验室生物标志物,但迄今为止有关其作用的数据尚不明确。异柠檬酸脱氢酶(IDH)基因突变的患者罹患 VTE 的风险较低,IDH 突变与抑制组织因子(TF)和荚膜蛋白的产生有关,而组织因子和荚膜蛋白是研究最多的导致血栓栓塞并发症发生的分子[2]。VTE 的主要特异性标志物是基于免疫组化方法,只有通过对肿瘤材料进行组织学检查才能获得。因此,寻找可用于评估静脉血栓栓塞并发症风险的无创生物标志物非常重要。在本综述中,我们将重点介绍在这一主题方面积累的知识。
{"title":"Molecular mechanisms of thrombotic complications in glial tumors","authors":"A. V. Savelyeva, Y. Zhilenkova, M. A. Simakova, O. V. Sirotkina","doi":"10.18705/2782-3806-2024-4-2-87-95","DOIUrl":"https://doi.org/10.18705/2782-3806-2024-4-2-87-95","url":null,"abstract":"Cancer patients are at increased risk of venous thromboembolic complications (VTE), which are the second leading cause of death in these patients. Moreover, the maximum incidence of VTE occurs in tumors of the central nervous system [1]. Research is being conducted to identify laboratory biomarkers of increased risk of VTE, but to date data on their role are ambiguous. Patients with a mutation in the isocitrate dehydrogenase (IDH) gene are at lower risk of VTE, and the IDH mutation is associated with suppression of the production of tissue factor (TF) and podoplanin, the most studied molecules responsible for the occurrence of thromboembolic complications [2]. The main specific markers of VTE are based on immunohistochemical methods, which are possible only with histological examination of the tumor material. Therefore, it is important to find noninvasive biomarkers that could be used to assess the risk of venous thromboembolic complications. In this review, we will focus on highlighting the accumulated knowledge on this theme.","PeriodicalId":499018,"journal":{"name":"Russian Journal for Personalized Medicine","volume":"2 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141356318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blinatumomab in pediatric acute lymphoblastic leukemia: one center experience Blinatumomab 治疗小儿急性淋巴细胞白血病:一个中心的经验
Pub Date : 2024-06-11 DOI: 10.18705/2782-3806-2024-4-2-156-169
N. V. Muliarova, A. Smirnova, S. Lapaeva, Y. Toshina, Y. Dinikina
Background. Despite the successes achieved in the treatment of B-cell acute lymphoblastic leukemia (B-ALL), overcoming the toxicity of standard chemotherapy regimens and the treatment of relapsed/refractory (r/r) forms of the disease remains relevant. The most promising option is to use immunotherapy (IT), including a monoclonal antibody blinatumomab (BM). The purpose of the study. To analyze indications of using, as well as efficacy and tolerability of BM in children with V-ALL. Materials and methods. From April 2016 to January 2024 a retrospective assessment of using of BM in children with B-ALL in the chemotherapy department of oncohematological diseases and TCM for children in Almazov National Medical Research Centre was performed. Results. The study included 53 patients, including 28 (53 %) girls and 25 (47 %) boys with median age of 7,7 (2,08–19,8) years. Indications for using of BM were as follows: (1) consolidation of remission (CR) with primary ALL (n = 17, 32 %); (2) persistence of minimal residual disease (MRD) (n = 23, 43 %) after completion of chemotherapy (CT) induction or before the stage of allogeneic haematopoietic stem cell transplantation (alloHSCT); (3) replacement of the standard CR due to the previous toxicity of СT or other contraindications to its implementation (n = 12, 23 %); (4) salvage therapy for r/r ALL (n = 1, 1,9 %). The status of MRD-negative remission after the 1st course of IT was achieved in 89 % of cases. Therapy using BM in a patient with the r/r ALL and total blast infiltration of the bone marrow was effective and facilitated reducing the tumor population to 7,2% by day 15 of therapy, however, there was a fatal outcome due to development and progression of preexisted severe infection. The most common variants of grade III–IV toxicity were leuko-/neutropenia (28 %) and neurotoxicity (3,7 %). BM dose reduction for the purpose of relieving toxicity was required in 19 % of patients, while the median days of therapy with dose reduction was 4. Corticosteroids were used for this purpose in 11 % of cases, antibacterial therapy — in 13 %. At the time of results evalution, there were no relapses of the disease in the study group. The article analyzes the international experience of using BM in patients with B-ALL.Conclusion. Our experience and the presented literature data demonstrate a reasonable expansion of indications for using of BM in children with B-ALL with high efficacy and satisfactory toxicity profile.
背景。尽管在治疗 B 细胞急性淋巴细胞白血病(B-ALL)方面取得了成功,但克服标准化疗方案的毒性和治疗复发/难治性(r/r)白血病仍是当务之急。最有希望的方案是使用免疫疗法(IT),包括单克隆抗体 blinatumomab (BM)。研究目的分析 BM 在 V-ALL 儿童中的使用适应症、疗效和耐受性。材料与方法。自2016年4月至2024年1月,在阿尔马佐夫国立医学研究中心儿童肿瘤血液病和中医化疗科对B-ALL患儿使用BM的情况进行了回顾性评估。研究结果研究共纳入 53 名患者,包括 28 名女孩(53%)和 25 名男孩(47%),中位年龄为 7.7 岁(2.08-19.8 岁)。使用 BM 的适应症如下:(1) 原发性 ALL 患者巩固缓解(CR)(17 人,32%);(2) 在完成诱导化疗(CT)后或异基因造血干细胞移植(alloHSCT)阶段前,最小残留病(MRD)持续存在(23 人,43%);(3) 由于СT之前的毒性或其他禁忌症而替代标准CR(12人,23%);(4) r/r ALL的挽救治疗(1人,1.9%)。89%的病例在第一个IT疗程后达到了MRD阴性的缓解状态。对一名患有r/r ALL且骨髓完全被疱疹浸润的患者使用BM进行治疗是有效的,有助于在治疗的第15天将肿瘤数量减少到7.2%,但是,由于之前存在的严重感染的发生和发展,出现了致命的结果。最常见的III-IV级毒性变异是白细胞/中性粒细胞减少(28%)和神经毒性(3.7%)。有 19% 的患者需要减少 BM 剂量以缓解毒性,而减少剂量治疗的中位天数为 4 天。为此目的使用皮质类固醇的病例占 11%,使用抗菌疗法的病例占 13%。在结果评估时,研究组中没有出现复发病例。文章分析了在 B-ALL 患者中使用 BM 的国际经验。我们的经验和所提供的文献数据表明,BM 在 B-ALL 儿童患者中的适应症有了合理的扩展,而且疗效显著,毒性也令人满意。
{"title":"Blinatumomab in pediatric acute lymphoblastic leukemia: one center experience","authors":"N. V. Muliarova, A. Smirnova, S. Lapaeva, Y. Toshina, Y. Dinikina","doi":"10.18705/2782-3806-2024-4-2-156-169","DOIUrl":"https://doi.org/10.18705/2782-3806-2024-4-2-156-169","url":null,"abstract":"Background. Despite the successes achieved in the treatment of B-cell acute lymphoblastic leukemia (B-ALL), overcoming the toxicity of standard chemotherapy regimens and the treatment of relapsed/refractory (r/r) forms of the disease remains relevant. The most promising option is to use immunotherapy (IT), including a monoclonal antibody blinatumomab (BM). The purpose of the study. To analyze indications of using, as well as efficacy and tolerability of BM in children with V-ALL. Materials and methods. From April 2016 to January 2024 a retrospective assessment of using of BM in children with B-ALL in the chemotherapy department of oncohematological diseases and TCM for children in Almazov National Medical Research Centre was performed. Results. The study included 53 patients, including 28 (53 %) girls and 25 (47 %) boys with median age of 7,7 (2,08–19,8) years. Indications for using of BM were as follows: (1) consolidation of remission (CR) with primary ALL (n = 17, 32 %); (2) persistence of minimal residual disease (MRD) (n = 23, 43 %) after completion of chemotherapy (CT) induction or before the stage of allogeneic haematopoietic stem cell transplantation (alloHSCT); (3) replacement of the standard CR due to the previous toxicity of СT or other contraindications to its implementation (n = 12, 23 %); (4) salvage therapy for r/r ALL (n = 1, 1,9 %). The status of MRD-negative remission after the 1st course of IT was achieved in 89 % of cases. Therapy using BM in a patient with the r/r ALL and total blast infiltration of the bone marrow was effective and facilitated reducing the tumor population to 7,2% by day 15 of therapy, however, there was a fatal outcome due to development and progression of preexisted severe infection. The most common variants of grade III–IV toxicity were leuko-/neutropenia (28 %) and neurotoxicity (3,7 %). BM dose reduction for the purpose of relieving toxicity was required in 19 % of patients, while the median days of therapy with dose reduction was 4. Corticosteroids were used for this purpose in 11 % of cases, antibacterial therapy — in 13 %. At the time of results evalution, there were no relapses of the disease in the study group. The article analyzes the international experience of using BM in patients with B-ALL.Conclusion. Our experience and the presented literature data demonstrate a reasonable expansion of indications for using of BM in children with B-ALL with high efficacy and satisfactory toxicity profile.","PeriodicalId":499018,"journal":{"name":"Russian Journal for Personalized Medicine","volume":"63 16","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141358464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Рathomorphological features of recurrent meningiomas 复发性脑膜瘤的病理形态特征
Pub Date : 2024-06-11 DOI: 10.18705/2782-3806-2024-4-2-106-113
V. V. Ushanov, K. K. Kukanov, A. A. Paltsev, A. S. Tsyndyaykina, N. A. Zayachkovsky, M. V. Pryanikov, Yu. M. Zabrodskaya
Background. Meningiomas are common tumors of the central nervous system, most of which are benign. Anaplastic and atypical meningiomas, which together account for 25 % of all meningiomas, have a high recurrence rate even after gross total resection and radiotherapy, which determines a significantly worse prognosis. The mechanisms of recurrence remain poorly understood.Purpose. To assess the significance of arachnoid granulations in the recurrence of meningiomas; to present our own clinical case; to make the review of the literature on this topic.Materials and methods. We searched for publications in the Pubmed, EMBASE, Cohrane Library, and eLibrary databases published between the beginning of database management to February 2023 on the issue of the role of arachnoid granulation in meningioma reccurence. The materials of the desease history and results of histological examination of 71-year-old with intracranial meningioma who were treated in Almazov National Medical Research Center are used in this work.Results. The clinical case of intracranial meningioma surgery is described. Histological examination of the tumor revealed papillary meningioma, grade 3. Tumor growth of meningioma was found in the granulations of the arachnoid. According to the review the clinical case shows the importance of the arachnoid granulations in determining the clinical management for this group of patients.Conclusion. The presented clinical case and analysis of literature data demonstrates the importance of considering the structure of arachnoid granulations in patients with intracranial meningiomas, especially in the recurrent type of the disease. The role of granulations of the arachnoid membrane is currently “forgotten”, but the study of these important structures within the boundaries of the tumor field can provide new information and mechanisms of oncogenesis, malignancy, and recurrence of meningiomas, which may serve as the basis for inclusion in the standards for making a final pathomorphological diagnosis in this groups of patients.
背景。脑膜瘤是中枢神经系统的常见肿瘤,大多数是良性的。无弹性脑膜瘤和非典型脑膜瘤占所有脑膜瘤的 25%,即使经过全切和放疗,其复发率也很高,这决定了其预后明显较差。人们对其复发机制仍知之甚少。评估蛛网膜肉芽在脑膜瘤复发中的重要性;介绍我们自己的临床病例;回顾有关这一主题的文献。我们在 Pubmed、EMBASE、Cohrane Library 和 eLibrary 数据库中检索了自数据库管理开始至 2023 年 2 月期间发表的有关蛛网膜肉芽在脑膜瘤复发中的作用的文献。本研究采用了在阿尔马佐夫国立医学研究中心接受治疗的71岁颅内脑膜瘤患者的病史材料和组织学检查结果。结果描述了颅内脑膜瘤手术的临床病例。肿瘤的组织学检查显示为乳头状脑膜瘤,3 级。脑膜瘤的肿瘤生长在蛛网膜的肉芽中。综述显示,该临床病例表明,蛛网膜肉芽在确定这类患者的临床治疗方案方面非常重要。本临床病例和文献资料分析表明,考虑蛛网膜肉芽结构对颅内脑膜瘤患者,尤其是复发性脑膜瘤患者非常重要。蛛网膜肉芽的作用目前已被 "遗忘",但对这些重要结构在肿瘤范围内的研究可为脑膜瘤的肿瘤发生、恶变和复发提供新的信息和机制,可作为将其纳入对这类患者进行最终病理形态学诊断的标准的依据。
{"title":"Рathomorphological features of recurrent meningiomas","authors":"V. V. Ushanov, K. K. Kukanov, A. A. Paltsev, A. S. Tsyndyaykina, N. A. Zayachkovsky, M. V. Pryanikov, Yu. M. Zabrodskaya","doi":"10.18705/2782-3806-2024-4-2-106-113","DOIUrl":"https://doi.org/10.18705/2782-3806-2024-4-2-106-113","url":null,"abstract":"Background. Meningiomas are common tumors of the central nervous system, most of which are benign. Anaplastic and atypical meningiomas, which together account for 25 % of all meningiomas, have a high recurrence rate even after gross total resection and radiotherapy, which determines a significantly worse prognosis. The mechanisms of recurrence remain poorly understood.Purpose. To assess the significance of arachnoid granulations in the recurrence of meningiomas; to present our own clinical case; to make the review of the literature on this topic.Materials and methods. We searched for publications in the Pubmed, EMBASE, Cohrane Library, and eLibrary databases published between the beginning of database management to February 2023 on the issue of the role of arachnoid granulation in meningioma reccurence. The materials of the desease history and results of histological examination of 71-year-old with intracranial meningioma who were treated in Almazov National Medical Research Center are used in this work.Results. The clinical case of intracranial meningioma surgery is described. Histological examination of the tumor revealed papillary meningioma, grade 3. Tumor growth of meningioma was found in the granulations of the arachnoid. According to the review the clinical case shows the importance of the arachnoid granulations in determining the clinical management for this group of patients.Conclusion. The presented clinical case and analysis of literature data demonstrates the importance of considering the structure of arachnoid granulations in patients with intracranial meningiomas, especially in the recurrent type of the disease. The role of granulations of the arachnoid membrane is currently “forgotten”, but the study of these important structures within the boundaries of the tumor field can provide new information and mechanisms of oncogenesis, malignancy, and recurrence of meningiomas, which may serve as the basis for inclusion in the standards for making a final pathomorphological diagnosis in this groups of patients.","PeriodicalId":499018,"journal":{"name":"Russian Journal for Personalized Medicine","volume":"7 26","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141356303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Features of the course of hydrocephalus in children after removal of a tumor of the posterior cranial fossa in the near and long term 儿童后颅窝肿瘤切除术后脑积水的近期和远期病程特点
Pub Date : 2024-06-11 DOI: 10.18705/2782-3806-2024-4-2-78-86
E. V. Fedorov, O. O. Shmeleva, A. V. Stepanenko, A. V. Kim
The article presents the results of a study of the dynamics of the development of persistent hydrocephalus in children after surgical removal of a tumor of the posterior cranial fossa in the early and late postoperative period. The analysis of the incidence of neuropsychological syndromes: cerebellar cognitive-affective syndrome and cerebellar mutism syndrome in children of this group was carried out. Retrospective analysis included 30 patients under 18 years of age with a diagnosis tumor of the posterior cranial fossa complicated by occlusive hydrocephalus. All patients were operated on in the conditions of the Department of Neurosurgery for Children No. 7 of the Almazov National Medical Research Centre. As a result of the study, the risk groups for maintaining hydrocephalus after removal of the tumor of the posterior cranial fossa were determined, and the frequency of occurrence of neuropsychological syndromes in the postoperative period was determined.
文章介绍了对后颅窝肿瘤手术切除后儿童在术后早期和晚期持续性脑积水发展动态的研究结果。研究还对该组患儿的神经心理综合征:小脑认知情感综合征和小脑缄默综合征的发病率进行了分析。回顾性分析包括30名诊断为后颅窝肿瘤并发闭塞性脑积水的18岁以下患者。所有患者均在阿尔马佐夫国立医学研究中心第七儿童神经外科进行了手术。研究结果确定了后颅窝肿瘤切除术后持续性脑积水的风险组别,并确定了术后神经心理综合征的发生频率。
{"title":"Features of the course of hydrocephalus in children after removal of a tumor of the posterior cranial fossa in the near and long term","authors":"E. V. Fedorov, O. O. Shmeleva, A. V. Stepanenko, A. V. Kim","doi":"10.18705/2782-3806-2024-4-2-78-86","DOIUrl":"https://doi.org/10.18705/2782-3806-2024-4-2-78-86","url":null,"abstract":"The article presents the results of a study of the dynamics of the development of persistent hydrocephalus in children after surgical removal of a tumor of the posterior cranial fossa in the early and late postoperative period. The analysis of the incidence of neuropsychological syndromes: cerebellar cognitive-affective syndrome and cerebellar mutism syndrome in children of this group was carried out. Retrospective analysis included 30 patients under 18 years of age with a diagnosis tumor of the posterior cranial fossa complicated by occlusive hydrocephalus. All patients were operated on in the conditions of the Department of Neurosurgery for Children No. 7 of the Almazov National Medical Research Centre. As a result of the study, the risk groups for maintaining hydrocephalus after removal of the tumor of the posterior cranial fossa were determined, and the frequency of occurrence of neuropsychological syndromes in the postoperative period was determined.","PeriodicalId":499018,"journal":{"name":"Russian Journal for Personalized Medicine","volume":"4 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141360786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare causes of cryptogenic stroke 隐源性中风的罕见病因
Pub Date : 2024-06-11 DOI: 10.18705/2782-3806-2024-4-2-170-179
S. A. Dreshina, S. N. Yanishevskiy
Stroke is one of the leading causes of mortality and disability in the world, which is why it is considered a key medical and social problem of modern medicine. According to international multicenter studies, ischemic stroke is the most frequent type of this condition. According to research, the pathogenetic subtype of ischemic stroke cannot be identified in a third of cases. Based on the TOAST classification, cryptogenic stroke requires exclusion of criteria for other pathogenetic subtypes. However, in clinical practice, the reasons for making this diagnosis are as follows: incomplete examination of the patient, negative test results, and identification of two or more causes. The high incidence and risk of recurrent ischemic events determines the need for a thorough diagnostic search in order to exclude rare causes and conduct reasonable secondary prophylaxis.
脑卒中是世界上导致死亡和残疾的主要原因之一,因此被认为是现代医学的一个重要医疗和社会问题。根据国际多中心研究,缺血性中风是最常见的中风类型。根据研究,三分之一的缺血性中风病例无法确定病因亚型。根据 TOAST 分类,隐源性卒中需要排除其他发病亚型的标准。然而,在临床实践中,做出这一诊断的原因如下:对患者的检查不全面、检测结果阴性、发现两种或两种以上病因。复发性缺血性事件的高发病率和高风险决定了需要进行彻底的诊断搜索,以排除罕见病因,并进行合理的二级预防。
{"title":"Rare causes of cryptogenic stroke","authors":"S. A. Dreshina, S. N. Yanishevskiy","doi":"10.18705/2782-3806-2024-4-2-170-179","DOIUrl":"https://doi.org/10.18705/2782-3806-2024-4-2-170-179","url":null,"abstract":"Stroke is one of the leading causes of mortality and disability in the world, which is why it is considered a key medical and social problem of modern medicine. According to international multicenter studies, ischemic stroke is the most frequent type of this condition. According to research, the pathogenetic subtype of ischemic stroke cannot be identified in a third of cases. Based on the TOAST classification, cryptogenic stroke requires exclusion of criteria for other pathogenetic subtypes. However, in clinical practice, the reasons for making this diagnosis are as follows: incomplete examination of the patient, negative test results, and identification of two or more causes. The high incidence and risk of recurrent ischemic events determines the need for a thorough diagnostic search in order to exclude rare causes and conduct reasonable secondary prophylaxis.","PeriodicalId":499018,"journal":{"name":"Russian Journal for Personalized Medicine","volume":"37 25","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141355643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modern methods of neuroimaging in the diagnosis of acute ischemic stroke 诊断急性缺血性脑卒中的现代神经影像学方法
Pub Date : 2024-06-11 DOI: 10.18705/2782-3806-2024-4-2129-138
L. I. Trushina, S. R. Sheriev, Ya. A. Filin, G. E. Trufanov, A. Efimtsev
Ischemic stroke is one of the leading causes of morbidity and mortality worldwide, resulting in significant social and economic consequences for the healthcare system. Moreover, ischemic stroke has a devastating psycho-emotional impact on both the patient and their family, causing anxiety and depressive disorders. To reduce the severity of neurological deficit, increase the percentage of patients returning to their previous level of social and daily activity, and decrease the rates of disability after a cerebrovascular catastrophe, it is necessary to provide the full spectrum of therapeutic and diagnostic assistance in the shortest possible time. Developing neuroimaging techniques help to timely and accurately diagnose cerebral stroke, differentiate ischemic damage from hemorrhagic, and also establish the time of onset of acute cerebrovascular accident.
缺血性脑卒中是全球发病和死亡的主要原因之一,给医疗系统带来了严重的社会和经济后果。此外,缺血性脑卒中对患者及其家人的心理情感也有破坏性影响,导致焦虑和抑郁障碍。为了减轻神经功能缺损的严重程度,提高患者恢复到以往社交和日常活动水平的比例,降低脑血管灾难后的致残率,有必要在尽可能短的时间内提供全方位的治疗和诊断帮助。神经影像学技术的发展有助于及时准确地诊断脑卒中,区分缺血性损伤和出血性损伤,并确定急性脑血管意外的发病时间。
{"title":"Modern methods of neuroimaging in the diagnosis of acute ischemic stroke","authors":"L. I. Trushina, S. R. Sheriev, Ya. A. Filin, G. E. Trufanov, A. Efimtsev","doi":"10.18705/2782-3806-2024-4-2129-138","DOIUrl":"https://doi.org/10.18705/2782-3806-2024-4-2129-138","url":null,"abstract":"Ischemic stroke is one of the leading causes of morbidity and mortality worldwide, resulting in significant social and economic consequences for the healthcare system. Moreover, ischemic stroke has a devastating psycho-emotional impact on both the patient and their family, causing anxiety and depressive disorders. To reduce the severity of neurological deficit, increase the percentage of patients returning to their previous level of social and daily activity, and decrease the rates of disability after a cerebrovascular catastrophe, it is necessary to provide the full spectrum of therapeutic and diagnostic assistance in the shortest possible time. Developing neuroimaging techniques help to timely and accurately diagnose cerebral stroke, differentiate ischemic damage from hemorrhagic, and also establish the time of onset of acute cerebrovascular accident.","PeriodicalId":499018,"journal":{"name":"Russian Journal for Personalized Medicine","volume":"28 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141355715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Russian Journal for Personalized Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1